Literature DB >> 11526908

Single domain camel antibodies: current status.

S Muyldermans1.   

Abstract

The antigen-binding capacity of the paired variable domains of an antibody is well established. The observation that the isolated heavy chains of anti-hapten antibodies retain some antigen-binding capacity in the absence of light chains led to attempts to obtain an even smaller antigen-binding unit in a VH format. Unfortunately, the poor solubility, the reduced affinity for the antigen and the irreproducible outcome showed that additional protein engineering would be required to successfully generate single-domain antibody fragments. By serendipity, it was discovered that this engineering is already performed continuously in nature. Part of the humoral immune response of camels and llamas is based largely on heavy-chain antibodies where the light chain is totally absent. These unique antibody isotypes interact with the antigen by virtue of only one single variable domain, referred to as VHH. Despite the absence of the VH-VL combinatorial diversity, these heavy-chain antibodies exhibit a broad antigen-binding repertoire by enlarging their hypervariable regions. Methods are described to tap the VHH repertoire of an immunised dromedary or llama. These VHH libraries contain a high titre of intact antigen-specific binders that were matured in vivo. Synthetic libraries of a 'camelised' human VH, a mouse VH or a camelid VHH scaffold with a randomised CDR3 could constitute a valid alternative to immune libraries to retrieve useful single-domain antigen binders. The recombinant VHH that are selected from such libraries are well expressed, highly soluble in aqueous environments and very robust. Some in vivo matured VHH were also shown to be potent enzyme inhibitors, and the low complexity of the antigen-binding site is an asset in the design of peptide mimetics. Because of their smaller size and the above properties, the VHH clearly offer added-value over conventional antibody fragments. They are expected to open perspectives as enzyme inhibitors and intrabodies, as modular building units for multivalent or multifunctional constructs, or as immuno-adsorbents and detection units in biosensors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11526908     DOI: 10.1016/s1389-0352(01)00021-6

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  151 in total

1.  Single-domain antibody fragments with high conformational stability.

Authors:  Mireille Dumoulin; Katja Conrath; Annemie Van Meirhaeghe; Filip Meersman; Karel Heremans; Leon G J Frenken; Serge Muyldermans; Lode Wyns; Andre Matagne
Journal:  Protein Sci       Date:  2002-03       Impact factor: 6.725

2.  Contributions of conventional and heavy-chain IgG to immunity in fetal, neonatal, and adult alpacas.

Authors:  L P Daley-Bauer; S R Purdy; M C Smith; L F Gagliardo; W C Davis; J A Appleton
Journal:  Clin Vaccine Immunol       Date:  2010-10-06

3.  Molecular imprint of enzyme active site by camel nanobodies: rapid and efficient approach to produce abzymes with alliinase activity.

Authors:  Jiang-Wei Li; Lijie Xia; Youhong Su; Hongchun Liu; Xueqing Xia; Qinxia Lu; Chunjin Yang; Kalbinur Reheman
Journal:  J Biol Chem       Date:  2012-02-28       Impact factor: 5.157

4.  Diabody mixture providing full protection against experimental scorpion envenoming with crude Androctonus australis venom.

Authors:  Anne di Tommaso; Matthieu O Juste; Marie-France Martin-Eauclaire; Isabelle Dimier-Poisson; Philippe Billiald; Nicolas Aubrey
Journal:  J Biol Chem       Date:  2012-02-28       Impact factor: 5.157

5.  Structure of a shark IgNAR antibody variable domain and modeling of an early-developmental isotype.

Authors:  Victor A Streltsov; Jennifer A Carmichael; Stewart D Nuttall
Journal:  Protein Sci       Date:  2005-09-30       Impact factor: 6.725

6.  Masked selection: a straightforward and flexible approach for the selection of binders against specific epitopes and differentially expressed proteins by phage display.

Authors:  Klervi Even-Desrumeaux; Damien Nevoltris; Marie Noelle Lavaut; Karima Alim; Jean-Paul Borg; Stéphane Audebert; Brigitte Kerfelec; Daniel Baty; Patrick Chames
Journal:  Mol Cell Proteomics       Date:  2013-12-20       Impact factor: 5.911

7.  Protein production in Yarrowia lipolytica via fusion to the secreted lipase Lip2p.

Authors:  Thomas Hofmeyer; Siyavuya Ishmael Bulani; Julius Grzeschik; Simon Krah; Bernhard Glotzbach; Christina Uth; Olga Avrutina; Michael Brecht; Hans Ulrich Göringer; Petrus van Zyl; Harald Kolmar
Journal:  Mol Biotechnol       Date:  2014-01       Impact factor: 2.695

8.  Orally fed seeds producing designer IgAs protect weaned piglets against enterotoxigenic Escherichia coli infection.

Authors:  Vikram Virdi; Annelies Coddens; Sylvie De Buck; Sam Millet; Bruno Maria Goddeeris; Eric Cox; Henri De Greve; Ann Depicker
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-25       Impact factor: 11.205

9.  High affinity anti-inorganic material antibody generation by integrating graft and evolution technologies: potential of antibodies as biointerface molecules.

Authors:  Takamitsu Hattori; Mitsuo Umetsu; Takeshi Nakanishi; Takanari Togashi; Nozomi Yokoo; Hiroya Abe; Satoshi Ohara; Tadafumi Adschiri; Izumi Kumagai
Journal:  J Biol Chem       Date:  2009-12-31       Impact factor: 5.157

10.  Intracellular expression of a single domain antibody reduces cytotoxicity of 15-acetyldeoxynivalenol in yeast.

Authors:  Patrick J Doyle; Hanaa Saeed; Anne Hermans; Steve C Gleddie; Greg Hussack; Mehdi Arbabi-Ghahroudi; Charles Seguin; Marc E Savard; C Roger Mackenzie; J Christopher Hall
Journal:  J Biol Chem       Date:  2009-09-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.